TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/26/26 17:42 | 5/21/26 | PHVS | Pharvaris N.V. | P7 | Health | Drug | Pharmaceutical Preparations | Nassif David W. | MA | O | CFO , CL | S | -303 | 30.31 | 0 | -10 | -8 | 120 | D | ||||||||||||||
9/4/18 19:39 | 8/30/18 | STDY | Steadymed Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nassif David W. | CA | O | EVP,CFO | S.d | -99 | 4.46 | 0 | -22 | -100 | 0 | D | ||||||||||||||
7/9/18 16:02 | 7/5/18 | STDY | Steadymed Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nassif David W. | CA | O | EVP,CFO | S | -55 | 4.50 | 0 | -12 | -35 | 22 | D | ||||||||||||||
7/3/18 14:40 | 7/2/18 | STDY | Steadymed Ltd. | L3 | Health | Drug | Pharmaceutical Preparations | Nassif David W. | CA | O | EVP,CFO | S | -45 | 4.50 | 0 | -10 | -23 | 34 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |